Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
The interferon beta-1b 16-year...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
The interferon beta-1b 16-year long-term follow-up study: Neutralizing antibodies and clinical outcomes
Bibliographic Details
Main Authors:
Reder, A
,
Ebers, G
,
Goodin, D
,
Li, D
,
Traboulsee, A
,
Beckman, K
,
Konieczny, A
Format:
Conference item
Published:
2008
Holdings
Description
Similar Items
Staff View
Description
Summary:
Similar Items
The final results of the interferon beta-1b 16-year long-term follow-up study
by: Ebers, G, et al.
Published: (2006)
Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study.
by: Ebers, G, et al.
Published: (2009)
Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS.
by: Reder, A, et al.
Published: (2010)
Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis
by: Goodin, D, et al.
Published: (2012)
Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis.
by: Goodin, D, et al.
Published: (2012)